ABSTRACT Introduction: VaxigripTetra™(IIV4; Sanofi Pasteur) is a quadrivalent split-virion
influenza vaccine approved in Europe in 2016 for individuals≥ 3 years of age. IIV4 builds …

ABSTRACT Introduction Quadrivalent Influenza Vaccine (Sinovac Biotech) is a quadrivalent
split-virion-inactivated influenza vaccine approved in China in June 2020 for individuals≥ 3 …

Seasonal influenza is recognized to be a significant public health problem and a cause of
death, especially in fragile persons. In nursing homes (NHs), vaccination for both residents …

Safety surveillance is required for each season's influenza vaccines to rapidly detect and
evaluate potential new safety concerns before the peak period of immunization. Here we …

ABSTRACT The European Medicines Agency requires Enhanced Passive Safety
Surveillance (EPSS) for all seasonal influenza vaccines. Here, we report the EPSS results …

Fluorescently labeled lectins are useful tools for in vivo and in vitro studies of the structure
and function of tissues and various pathogens such as viruses, bacteria, and fungi. For the …

Annual vaccination is the most effective way to prevent seasonal influenza illness. Instituto
Butantan (IB) performed clinical studies with its 2013, 2014 and 2015 seasonal trivalent …

Objective: The aim of the study was to evaluate the safety and tolerance of influenza
vaccines for the northern and southern hemispheres in Polish elite athletes participating in …

Influenza is a highly contagious, acute respiratory viral infection, responsible for annual
epidemics causing severe morbidity and mortality. Vaccination remains the most effective …

Background To enhance the production and availability of influenza vaccines in different
regions of the world is paramount to mitigate the global burden of this disease. Instituto …